Efficacy of Intravitreal Bevacizumab in Treatment of Proliferative Type 2 Idiopathic Juxtafoveal Telangiectasia

Efficacy of Intravitreal Bevacizumab in Treatment of Proliferative Type 2 Idiopathic Juxtafoveal Telangiectasia

Objectives: To evaluate the effectiveness of intravitreal bevacizumab (IVB) in patients with subretinal neovascularization secondary to type 2 juxtafoveal telangiectasia. Materials and Methods: Ten eyes of 10 patients were included in this retrospective study. All cases were treated with IVB (1.25...

Full description

Bibliographic Details
Main Authors: Ökkeş Baz, İhsan Yılmaz, Cengiz Alagöz, Ali Demircan, İrfan Perente, Abdullah Özkaya, Muhittin Taşkapılı
Format: Article
Language:English
Published: Galenos Yayinevi 2017-06-01
Series:Türk Oftalmoloji Dergisi
Subjects:
Juxtafoveal telangiectasia
subretinal neovascularization
bevacizumab
Online Access:http://oftalmoloji.org/article_14968/Efficacy-Of-Intravitreal-Bevacizumab-In-Treatment-Of-Proliferative-Type-2-Idiopathic-Juxtafoveal-Telangiectasia

Internet

http://oftalmoloji.org/article_14968/Efficacy-Of-Intravitreal-Bevacizumab-In-Treatment-Of-Proliferative-Type-2-Idiopathic-Juxtafoveal-Telangiectasia

Similar Items